skip to content

Department of Medicine

Read more at: Combining antibiotics to tackle antimicrobial resistance

Combining antibiotics to tackle antimicrobial resistance

27 March 2025

William Hope (University of Liverpool), our professor Sharon Peacock and colleagues have published a new comment on Nature Microbiology, suggesting combining antibiotics remains a promising approach to treat patients and to prevent the emergence of antimicrobial resistance.


Read more at: Maxion Therapeutics, co-founded by Dr John McCafferty, raises £58 million Series A financing
Headshot of CTO, CEO and CSO of Maxion Therapeutics

Maxion Therapeutics, co-founded by Dr John McCafferty, raises £58 million Series A financing

18 March 2025

Maxion Therapeutics, a Cambridge-based biotechnology company co-founded by Dr. John McCafferty, Associate Professor at CITIID and the Department of Medicine, University of Cambridge, has successfully raised $72 million in an oversubscribed Series A financing round. The company is developing antibody-based KnotBody® drugs...


Read more at: When inflammation goes too far
Clare Bryant in her lab

When inflammation goes too far

13 March 2025

Clare Bryant takes a closer look at inflammation, and when our defence systems go too far.


Read more at: Microbiome: ‘Good’ gut bacteria may protect against Salmonella infection
Gut bacterium

Microbiome: ‘Good’ gut bacteria may protect against Salmonella infection

4 March 2025

New research from scientists at the University of Cambridge reveals how ‘good’ gut bacteria help protect against Salmonella, a major cause of food poisoning.


Read more at: Carmel McEniery and the POPPY team are highly commended in the 2024 Cambridge Awards for Research Impact and Engagement
The Poppy team visit Addenbrooke’s Hospital in Cambridge

Carmel McEniery and the POPPY team are highly commended in the 2024 Cambridge Awards for Research Impact and Engagement

20 February 2025

We're delighted to announce that Dr Carmel McEniery, Principal Research Associate at the Department of Medicine, has been Highly Commended together with the POPPY team in the Established Academic Award of the Cambridge Awards 2024 for their exemplary work in raising awareness, fostering collaborations, and enriching research to improve women's health.


Read more at: Prioritise vaccine boosters for vulnerable immunocompromised patients

Prioritise vaccine boosters for vulnerable immunocompromised patients

13 February 2025

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University of Cambridge has shown.


Read more at: New study shows how gut microbes affect cancer immunotherapy responses
bacteria

New study shows how gut microbes affect cancer immunotherapy responses

12 February 2025

Lipopolysaccharide (LPS) produced in gut microbiota could influence how well cancer patients respond to immunotherapy treatments, as shown in a study published this week in Nature Microbiology .


Read more at: Professor Duncan Richards appointed as Head of Department of Medicine
Professor Duncan Richards

Professor Duncan Richards appointed as Head of Department of Medicine

15 January 2025


Read more at: Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases
Dave Thomas and Nic Wisniacki

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases

15 January 2025

The Cambridge-GSK Translational Immunology Collaboration (CG-TIC) combines University and GSK expertise in the science of the immune system, AI and clinical development with access to patients and their data provided by Cambridge University Hospitals.


Read more at: 10 Cambridge spinouts changing the story of cancer

10 Cambridge spinouts changing the story of cancer

15 January 2025

University spinouts are supported through their commercialisation journey by the University's innovation arm, Cambridge Enterprise. Meet 10 of our spinouts, all committed to changing the story of cancer.


Researchers in the news

Clare Bryant (Medicine/Veterinary Medicine/Queens’ College) speaks to BBC Radio 4’s Inside Science about Google Co-Scientist. Clare was given early access to the AI system to hunt for molecular switches that cause severe diseases in humans when pathogens leap between species.


Clare Bryant (Medicine/Veterinary Medicine/Queens’ College) speaks to The Telegraph about inflammation, why it can cause problems and ways that we might lower levels of it in the body.


Ravi Gupta (Cambridge Institute for Therapeutic Immunology and Infectious Disease) talks to the Mirror about the new Covid-19 ‘Cicada’ variant, which appears to be better at evading the body’s immune defences.


Andrea Lavinio (Medicine) is to lead a trial to assess whether a targeted cooling collar can improve patients' recovery from traumatic brain injuries, according to BBC Online


Ian Wilkinson (Medicine) tells the Guardian that tackling high blood pressure earlier could give people many more years of healthy life. He argues that we should begin monitoring blood pressure in secondary school and encourage a reduction in people’s salt intake and obesity.


Ravi Gupta (CITIID) speaks to New Scientist about a person who was left HIV-free after a transplant of non-HIV resistant stem cells.


Miles Parkes and Nuru Noor (Medicine) led a study which showed that using biologic drugs soon after a diagnosis of Crohn's disease, rather than when symptoms worsen, is five times more effective at controlling the disease, as reported by the BBCRead more on the CUH website.


Clare Bryant (Medicine) spoke to the Financial Times about new research in which scientists have edited the genes of pigs to resist swine fever. She said that just as there is no will to vaccinate animals in some countries, there might also be reluctance to use gene editing.


Shuaib Nasser (Medicine) spoke to the Daily Mail about a new nasal spray developed to treat life-threatening allergic reactions that is now available in the UK, saying that its compactness and ease of use may make it more practical than current devices for administering adrenaline.


Sharon Peacock (PACE) appeared on the Naked Scientists Titans of Science podcast talking about her work on whole genome sequencing of pathogens such as MRSA and SARS CoV-2, and studies of antimicrobial resistance.


Mike Weekes (ImID) spoke to the Independent about the risks of warmer temperatures and altered rainfall patterns caused by climate change leading to a spread of tropical diseases to Europe and the UK.